These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 9681596)

  • 1. The relationships between insulin and plasminogen activator inhibitor 1 levels: assessment in groups of subjects with dyslipidaemia and hypertension.
    Akanji AO; Al-Shayji I
    Clin Chim Acta; 1998 Jun; 274(1):41-52. PubMed ID: 9681596
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lipoprotein(a), tissue plasminogen activator and plasminogen activator inhibitor 1 levels in hyperlipidaemic patients in Kuwait.
    Akanji AO; Abdullah A; Tahzeeb S
    Eur J Clin Invest; 1997 May; 27(5):380-6. PubMed ID: 9179544
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diabetic dyslipidaemia in Kuwait.
    Akanji AO
    Med Princ Pract; 2002; 11 Suppl 2():47-55. PubMed ID: 12444310
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Plasminogen activator inhibitor-1 (PAI-1) 4G/5G and angiotensin converting enzyme (ACE) I/D gene polymorphisms and fibrinolytic activity in patients with essential hypertension and dyslipidemia].
    Jastrzebska M; Widecka K; Ciechanowicz A; Goracy I; Wesołowska T; Torbus-Lisiecka B; Foltyńska-Nowakowska A; Naruszewicz M
    Pol Arch Med Wewn; 2005 Jan; 113(1):7-20. PubMed ID: 16130596
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum triglycerides and blood coagulation factors VII and X, and plasminogen activator inhibitor-1.
    Ohni M; Mishima K; Nakajima K; Yamamoto M; Hata Y
    J Atheroscler Thromb; 1995; 2 Suppl 1():S41-6. PubMed ID: 9225231
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased plasminogen activator inhibitor-1 activity in offspring of type 2 diabetic patients: lack of association with plasma insulin levels.
    Gürlek A; Bayraktar M; Kirazli S
    Diabetes Care; 2000 Jan; 23(1):88-92. PubMed ID: 10857975
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Insulin and PAI-1 levels during oral glucose tolerance test in patients with coronary heart disease.
    Seljeflot I; Eritsland J; Torjesen P; Arnesen H
    Scand J Clin Lab Invest; 1994 May; 54(3):241-6. PubMed ID: 8036449
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relationships of blood pressure to fibrinolysis: influence of anthropometry, metabolic profile and behavioural variables.
    Cigolini M; Targher G; Seidell JC; Tonoli M; Schiavon R; Agostino G; De Sandre G
    J Hypertens; 1995 Jun; 13(6):659-66. PubMed ID: 7594424
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impaired fibrinolysis and insulin resistance in patients with hypertension.
    Jeng JR; Sheu WH; Jeng CY; Huang SH; Shieh SM
    Am J Hypertens; 1996 May; 9(5):484-90. PubMed ID: 8735180
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Determinants of glycated LDL levels in nondiabetic and diabetic hyperlipidaemic patients in Kuwait.
    Akanji AO; Abdella N; Mojiminiyi OA
    Clin Chim Acta; 2002 Mar; 317(1-2):171-6. PubMed ID: 11814472
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Absence of profound hyperinsulinism in polycystic ovary syndrome is associated with subtle elevations in the plasminogen activator inhibitor system.
    Sills ES; Drews CD; Perloe M; Tucker MJ; Kaplan CR; Palermo GD
    Gynecol Endocrinol; 2003 Jun; 17(3):231-7. PubMed ID: 12857431
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of troglitazone on blood concentrations of plasminogen activator inhibitor 1 in patients with type 2 diabetes and in lean and obese normal subjects.
    Kruszynska YT; Yu JG; Olefsky JM; Sobel BE
    Diabetes; 2000 Apr; 49(4):633-9. PubMed ID: 10871202
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Proinsulin-like molecules and plasminogen activator inhibitor type 1 (PAI-1) activity in diabetic and non-diabetic subjects with and without myocardial infarction.
    Gray RP; Panahloo A; Mohamed-Ali V; Patterson DL; Yudkin JS
    Atherosclerosis; 1997 Apr; 130(1-2):171-8. PubMed ID: 9126661
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relation of depressive mood to plasminogen activator inhibitor, tissue plasminogen activator, and fibrinogen levels in patients with versus without coronary heart disease.
    Lahlou-Laforet K; Alhenc-Gelas M; Pornin M; Bydlowski S; Seigneur E; Benetos A; Kierzin JM; Scarabin PY; Ducimetiere P; Aiach M; Guize L; Consoli SM
    Am J Cardiol; 2006 May; 97(9):1287-91. PubMed ID: 16635597
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Elevation of plasminogen activator inhibitor 1 in borderline hypertension is linked to concomitant metabolic disturbances.
    Lemne C; De Faire U
    Eur J Clin Invest; 1996 Aug; 26(8):692-7. PubMed ID: 8872066
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PAI-1 in human hypertension: relation to hypertensive groups.
    Srikumar N; Brown NJ; Hopkins PN; Jeunemaitre X; Hunt SC; Vaughan DE; Williams GH
    Am J Hypertens; 2002 Aug; 15(8):683-90. PubMed ID: 12160190
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gender differences in the relationships between plasma plasminogen activator inhibitor-1 activity and factors linked to the insulin resistance syndrome in essential hypertension.
    Toft I; Bønaa KH; Ingebretsen OC; Nordøy A; Birkeland KI; Jenssen T
    Arterioscler Thromb Vasc Biol; 1997 Mar; 17(3):553-9. PubMed ID: 9102176
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hypertension and the metabolic cardiovascular syndrome: special reference to premenopausal women.
    Os I; Nordby G
    J Cardiovasc Pharmacol; 1992; 20 Suppl 8():S15-21. PubMed ID: 1283764
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Causal Effect of Plasminogen Activator Inhibitor Type 1 on Coronary Heart Disease.
    Song C; Burgess S; Eicher JD; O'Donnell CJ; Johnson AD
    J Am Heart Assoc; 2017 May; 6(6):. PubMed ID: 28550093
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plasminogen activator inhibitor (PAI-1) and non-insulin-dependent diabetes in Pima Indians, south Asians and Europeans. Populations at varying risk of NIDDM and coronary artery disease.
    Nagi DK; Knowler WC; Hanson RL; Ali VM; Yudkin JS
    Thromb Haemost; 1996 Jun; 75(6):921-7. PubMed ID: 8822587
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.